Exploration of target molecules for molecular imaging of inflammatory bowel disease

Kei Higashikawa, Naoki Akada, Katsuharu Yagi, Keiko Watanabe, Shinichiro Kamino, Yousuke Kanayama, Makoto Hiromura, Shuichi Enomoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Molecular imaging technology is a powerful tool for the diagnosis of inflammatory bowel disease (IBD) and the efficacy evaluation of various drug therapies for it. However, it is difficult to elucidate directly the relationships between the responsible molecules and IBD using existing probes. Therefore, the development of an alternative probe that is able to elucidate the pathogenic mechanism and provide information on the appropriate guidelines for treatment is earnestly awaited. In this study, we investigated pathognomonic molecules in the intestines of model mice. The accumulation of fluorine-18 fluorodeoxyglucose (18F-FDG) in the inflamed area of the intestines of dextran sulfate sodium (DSS)- or indomethacin (IND)-induced IBD model mice was measured by positron emission tomography (PET) and autoradiography to confirm the inflamed area. The results suggested that the inflammation was selectively induced in the colons of mice by the administration of DSS, whereas it was induced mainly in the ilea and the proximal colons of mice by the administration of IND. To explore attractive target molecules for the molecular imaging of IBD, we evaluated the gene expression levels of cytokines and cytokine receptors in the inflamed area of the intestines of both model mice. We found that the expression levels of cytokines and cytokine receptors were significantly increased during the progression of IBD, whereas the expression levels were decreased as the mucosa began to heal. In particular, the expression levels of these molecules had already changed before the symptoms of IBD appeared. In addition, the alterations of cytokine and cytokine receptor expression levels indicated differences in the expression pattern depending on the pathogenic mechanism or the region of inflammation (e.g., TNF-α). Our results suggest that these cytokines or cytokine receptors participate in the pathogenesis of IBD and are valuable biomarkers for the detection of the different circumstances underlying inflammation by the molecular imaging method. Finally, the development of an imaging probe for our target molecules is expected to improve our understanding of the inflammatory conditions of IBD.

Original languageEnglish
Pages (from-to)416-421
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume410
Issue number3
DOIs
Publication statusPublished - Jul 8 2011
Externally publishedYes

Fingerprint

Molecular imaging
Molecular Imaging
Inflammatory Bowel Diseases
Cytokine Receptors
Molecules
Cytokines
Intestines
Dextran Sulfate
Fluorodeoxyglucose F18
Inflammation
Indomethacin
Colon
Drug therapy
Positron emission tomography
Biomarkers
Autoradiography
Ileum
Gene expression
Positron-Emission Tomography
Mucous Membrane

Keywords

  • Cytokine
  • Cytokine receptor
  • Fluorine-18 fluorodeoxyglucose
  • Inflammatory bowel disease
  • Molecular imaging

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Exploration of target molecules for molecular imaging of inflammatory bowel disease. / Higashikawa, Kei; Akada, Naoki; Yagi, Katsuharu; Watanabe, Keiko; Kamino, Shinichiro; Kanayama, Yousuke; Hiromura, Makoto; Enomoto, Shuichi.

In: Biochemical and Biophysical Research Communications, Vol. 410, No. 3, 08.07.2011, p. 416-421.

Research output: Contribution to journalArticle

Higashikawa, K, Akada, N, Yagi, K, Watanabe, K, Kamino, S, Kanayama, Y, Hiromura, M & Enomoto, S 2011, 'Exploration of target molecules for molecular imaging of inflammatory bowel disease', Biochemical and Biophysical Research Communications, vol. 410, no. 3, pp. 416-421. https://doi.org/10.1016/j.bbrc.2011.05.146
Higashikawa, Kei ; Akada, Naoki ; Yagi, Katsuharu ; Watanabe, Keiko ; Kamino, Shinichiro ; Kanayama, Yousuke ; Hiromura, Makoto ; Enomoto, Shuichi. / Exploration of target molecules for molecular imaging of inflammatory bowel disease. In: Biochemical and Biophysical Research Communications. 2011 ; Vol. 410, No. 3. pp. 416-421.
@article{4a5153786cc44e36b7e2e67ac0118810,
title = "Exploration of target molecules for molecular imaging of inflammatory bowel disease",
abstract = "Molecular imaging technology is a powerful tool for the diagnosis of inflammatory bowel disease (IBD) and the efficacy evaluation of various drug therapies for it. However, it is difficult to elucidate directly the relationships between the responsible molecules and IBD using existing probes. Therefore, the development of an alternative probe that is able to elucidate the pathogenic mechanism and provide information on the appropriate guidelines for treatment is earnestly awaited. In this study, we investigated pathognomonic molecules in the intestines of model mice. The accumulation of fluorine-18 fluorodeoxyglucose (18F-FDG) in the inflamed area of the intestines of dextran sulfate sodium (DSS)- or indomethacin (IND)-induced IBD model mice was measured by positron emission tomography (PET) and autoradiography to confirm the inflamed area. The results suggested that the inflammation was selectively induced in the colons of mice by the administration of DSS, whereas it was induced mainly in the ilea and the proximal colons of mice by the administration of IND. To explore attractive target molecules for the molecular imaging of IBD, we evaluated the gene expression levels of cytokines and cytokine receptors in the inflamed area of the intestines of both model mice. We found that the expression levels of cytokines and cytokine receptors were significantly increased during the progression of IBD, whereas the expression levels were decreased as the mucosa began to heal. In particular, the expression levels of these molecules had already changed before the symptoms of IBD appeared. In addition, the alterations of cytokine and cytokine receptor expression levels indicated differences in the expression pattern depending on the pathogenic mechanism or the region of inflammation (e.g., TNF-α). Our results suggest that these cytokines or cytokine receptors participate in the pathogenesis of IBD and are valuable biomarkers for the detection of the different circumstances underlying inflammation by the molecular imaging method. Finally, the development of an imaging probe for our target molecules is expected to improve our understanding of the inflammatory conditions of IBD.",
keywords = "Cytokine, Cytokine receptor, Fluorine-18 fluorodeoxyglucose, Inflammatory bowel disease, Molecular imaging",
author = "Kei Higashikawa and Naoki Akada and Katsuharu Yagi and Keiko Watanabe and Shinichiro Kamino and Yousuke Kanayama and Makoto Hiromura and Shuichi Enomoto",
year = "2011",
month = "7",
day = "8",
doi = "10.1016/j.bbrc.2011.05.146",
language = "English",
volume = "410",
pages = "416--421",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Exploration of target molecules for molecular imaging of inflammatory bowel disease

AU - Higashikawa, Kei

AU - Akada, Naoki

AU - Yagi, Katsuharu

AU - Watanabe, Keiko

AU - Kamino, Shinichiro

AU - Kanayama, Yousuke

AU - Hiromura, Makoto

AU - Enomoto, Shuichi

PY - 2011/7/8

Y1 - 2011/7/8

N2 - Molecular imaging technology is a powerful tool for the diagnosis of inflammatory bowel disease (IBD) and the efficacy evaluation of various drug therapies for it. However, it is difficult to elucidate directly the relationships between the responsible molecules and IBD using existing probes. Therefore, the development of an alternative probe that is able to elucidate the pathogenic mechanism and provide information on the appropriate guidelines for treatment is earnestly awaited. In this study, we investigated pathognomonic molecules in the intestines of model mice. The accumulation of fluorine-18 fluorodeoxyglucose (18F-FDG) in the inflamed area of the intestines of dextran sulfate sodium (DSS)- or indomethacin (IND)-induced IBD model mice was measured by positron emission tomography (PET) and autoradiography to confirm the inflamed area. The results suggested that the inflammation was selectively induced in the colons of mice by the administration of DSS, whereas it was induced mainly in the ilea and the proximal colons of mice by the administration of IND. To explore attractive target molecules for the molecular imaging of IBD, we evaluated the gene expression levels of cytokines and cytokine receptors in the inflamed area of the intestines of both model mice. We found that the expression levels of cytokines and cytokine receptors were significantly increased during the progression of IBD, whereas the expression levels were decreased as the mucosa began to heal. In particular, the expression levels of these molecules had already changed before the symptoms of IBD appeared. In addition, the alterations of cytokine and cytokine receptor expression levels indicated differences in the expression pattern depending on the pathogenic mechanism or the region of inflammation (e.g., TNF-α). Our results suggest that these cytokines or cytokine receptors participate in the pathogenesis of IBD and are valuable biomarkers for the detection of the different circumstances underlying inflammation by the molecular imaging method. Finally, the development of an imaging probe for our target molecules is expected to improve our understanding of the inflammatory conditions of IBD.

AB - Molecular imaging technology is a powerful tool for the diagnosis of inflammatory bowel disease (IBD) and the efficacy evaluation of various drug therapies for it. However, it is difficult to elucidate directly the relationships between the responsible molecules and IBD using existing probes. Therefore, the development of an alternative probe that is able to elucidate the pathogenic mechanism and provide information on the appropriate guidelines for treatment is earnestly awaited. In this study, we investigated pathognomonic molecules in the intestines of model mice. The accumulation of fluorine-18 fluorodeoxyglucose (18F-FDG) in the inflamed area of the intestines of dextran sulfate sodium (DSS)- or indomethacin (IND)-induced IBD model mice was measured by positron emission tomography (PET) and autoradiography to confirm the inflamed area. The results suggested that the inflammation was selectively induced in the colons of mice by the administration of DSS, whereas it was induced mainly in the ilea and the proximal colons of mice by the administration of IND. To explore attractive target molecules for the molecular imaging of IBD, we evaluated the gene expression levels of cytokines and cytokine receptors in the inflamed area of the intestines of both model mice. We found that the expression levels of cytokines and cytokine receptors were significantly increased during the progression of IBD, whereas the expression levels were decreased as the mucosa began to heal. In particular, the expression levels of these molecules had already changed before the symptoms of IBD appeared. In addition, the alterations of cytokine and cytokine receptor expression levels indicated differences in the expression pattern depending on the pathogenic mechanism or the region of inflammation (e.g., TNF-α). Our results suggest that these cytokines or cytokine receptors participate in the pathogenesis of IBD and are valuable biomarkers for the detection of the different circumstances underlying inflammation by the molecular imaging method. Finally, the development of an imaging probe for our target molecules is expected to improve our understanding of the inflammatory conditions of IBD.

KW - Cytokine

KW - Cytokine receptor

KW - Fluorine-18 fluorodeoxyglucose

KW - Inflammatory bowel disease

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=79960065016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960065016&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.05.146

DO - 10.1016/j.bbrc.2011.05.146

M3 - Article

VL - 410

SP - 416

EP - 421

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -